Omnicell Statistics
Total Valuation
Omnicell has a market cap or net worth of $1.39 billion. The enterprise value is $1.39 billion.
| Market Cap | 1.39B |
| Enterprise Value | 1.39B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Omnicell has 46.84 million shares outstanding. The number of shares has increased by 2.31% in one year.
| Current Share Class | 46.84M |
| Shares Outstanding | 46.84M |
| Shares Change (YoY) | +2.31% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | 102.42% |
| Float | 45.73M |
Valuation Ratios
The trailing PE ratio is 65.73 and the forward PE ratio is 22.33. Omnicell's PEG ratio is 38.40.
| PE Ratio | 65.73 |
| Forward PE | 22.33 |
| PS Ratio | 1.21 |
| Forward PS | 1.20 |
| PB Ratio | 1.11 |
| P/TBV Ratio | 4.96 |
| P/FCF Ratio | 11.15 |
| P/OCF Ratio | 8.52 |
| PEG Ratio | 38.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.01, with an EV/FCF ratio of 11.15.
| EV / Earnings | 65.78 |
| EV / Sales | 1.23 |
| EV / EBITDA | 20.01 |
| EV / EBIT | 110.99 |
| EV / FCF | 11.15 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.38 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 4.84 |
| Debt / FCF | 3.09 |
| Interest Coverage | 2.39 |
Financial Efficiency
Return on equity (ROE) is 1.73% and return on invested capital (ROIC) is 0.46%.
| Return on Equity (ROE) | 1.73% |
| Return on Assets (ROA) | 0.35% |
| Return on Invested Capital (ROIC) | 0.46% |
| Return on Capital Employed (ROCE) | 0.81% |
| Revenue Per Employee | $309,470 |
| Profits Per Employee | $5,772 |
| Employee Count | 3,670 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 6.62 |
Taxes
In the past 12 months, Omnicell has paid $12.71 million in taxes.
| Income Tax | 12.71M |
| Effective Tax Rate | 37.50% |
Stock Price Statistics
The stock price has increased by +14.85% in the last 52 weeks. The beta is 0.76, so Omnicell's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +14.85% |
| 50-Day Moving Average | 29.20 |
| 200-Day Moving Average | 38.09 |
| Relative Strength Index (RSI) | 52.20 |
| Average Volume (20 Days) | 441,806 |
Short Selling Information
The latest short interest is 2.46 million, so 5.24% of the outstanding shares have been sold short.
| Short Interest | 2.46M |
| Short Previous Month | 2.27M |
| Short % of Shares Out | 5.24% |
| Short % of Float | 5.37% |
| Short Ratio (days to cover) | 3.92 |
Income Statement
In the last 12 months, Omnicell had revenue of $1.14 billion and earned $21.18 million in profits. Earnings per share was $0.45.
| Revenue | 1.14B |
| Gross Profit | 491.12M |
| Operating Income | 12.56M |
| Pretax Income | -20.77M |
| Net Income | 21.18M |
| EBITDA | 69.63M |
| EBIT | 12.56M |
| Earnings Per Share (EPS) | $0.45 |
Balance Sheet
The company has $386.83 million in cash and $385.83 million in debt, giving a net cash position of $999,000 or $0.02 per share.
| Cash & Cash Equivalents | 386.83M |
| Total Debt | 385.83M |
| Net Cash | 999,000 |
| Net Cash Per Share | $0.02 |
| Equity (Book Value) | 1.26B |
| Book Value Per Share | 26.84 |
| Working Capital | 232.14M |
Cash Flow
In the last 12 months, operating cash flow was $163.69 million and capital expenditures -$38.68 million, giving a free cash flow of $125.02 million.
| Operating Cash Flow | 163.69M |
| Capital Expenditures | -38.68M |
| Free Cash Flow | 125.02M |
| FCF Per Share | $2.67 |
Margins
Gross margin is 43.24%, with operating and profit margins of 1.11% and 1.87%.
| Gross Margin | 43.24% |
| Operating Margin | 1.11% |
| Pretax Margin | 2.98% |
| Profit Margin | 1.87% |
| EBITDA Margin | 6.13% |
| EBIT Margin | 1.11% |
| FCF Margin | 11.01% |
Dividends & Yields
Omnicell does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.31% |
| Shareholder Yield | -2.31% |
| Earnings Yield | 1.52% |
| FCF Yield | 8.96% |
Analyst Forecast
The average price target for Omnicell is $44.83, which is 50.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $44.83 |
| Price Target Difference | 50.59% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 15.20% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Omnicell has an Altman Z-Score of 2.09 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.09 |
| Piotroski F-Score | 7 |